$7.52
arrow_drop_down1.44%Key Stats | |
---|---|
Open | $7.40 |
Prev. Close | $7.39 |
EPS | -11.22 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 7.11 | 7.75 |
52 Week Range | 1.42 | 15.10 |
Ratios | |
---|---|
Revenue | - |
EPS | -11.22 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
OHA is Administrative Agent and Sole Lender for Emergent BioSolutions Debt Refinancing
Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors
Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions
Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa
3 Promising Vaccine Stocks to Watch in the Event of an Mpox Surge
Why Emergent BioSolutions Stock Is Skyrocketing Today